pocketful logo light
pocketful logo light
Alembic Pharmaceuticals Ltd logo

Alembic Pharmaceuticals Ltd

NSE: APLLTD BSE: 533573

₹844.25

(0.53%)

Sun, 27 Sept 2026, 06:33 pm

mtf coin illustrationMTF 5x

Alembic Pharmaceuticals Share Price Live Chart

1 Day

(0.53%)

No Result Found

Summary

  • Market Cap (in Cr)

    14449.36

  • Net Profit (in Cr)

    582.01

  • P/B

    3.52

  • Sector P/E

    33.76

  • P/E

    31.31

  • EV/EBITDA

    18.25

  • Debt/Equity (Industry)

    0.16

  • Interest Cover (Industry)

    17.01

  • ROCE (Industry)

    16.41

  • RONW (Industry)

    14.52

  • ROE

    11.63

  • ROCE

    13.08

  • Debt/Equity

    0.18

  • EPS (TTM)

    37.11

  • Dividend Yield

    1.63

  • Book Value

    288.70

  • Interest Cover

    9.98

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters69.7469.7469.7469.6769.67
FII4.254.244.053.963.94
DII16.1816.1716.3016.4616.43
Public9.839.859.929.909.96
Government00000

Read More

Technical Analysis

RSI

65.39

MACD

8.85

50 DMA

822.97

200 DMA

783.83

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic954.48891.13863.02827.78799.67764.43701.08
Fibonacci891.13866.93851.98827.78803.58788.63764.43
Camarilla852.32846.51840.71827.78829.09823.29817.48

Pivots Level: Classic

R3

+126.70

954.48

R2

+63.35

891.13

R1

+35.23

863.02

827.78
827.78
Pivot Point
LTP: 863.75

S1

-28.12

799.67

S2

-63.35

764.43

S3

-126.70

701.08

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    841.29

  • 20-EMA

    832.85

  • 30-EMA

    828.45

  • 50-EMA

    820.87

  • 100-EMA

    807.59

  • 200-EMA

    813.54

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
15 May 2026board-meetingsAccounts, Dividend
05 Feb 2026board-meetingsQuarterly Results, Nine Months Results
04 Nov 2025board-meetingsQuarterly Results, Half Yearly Results
29 Jun 2025dividendFinal Dividend - Rs. - 1129 Jul 2025
11 Jun 2025agm
06 May 2025dividend₹11.00 Dividend /Share29 Jul 2025
21 Jun 2024agm
15 Jun 2024dividendFinal Dividend - Rs. - 1115 Jul 2024
09 May 2024dividend₹11.00 Dividend /Share15 Jul 2024
28 Jun 2023dividendFinal Dividend - Rs. - 828 Jul 2023

Read More

Peer Comparison

Alembic Pharmaceuticals Ltd logo

Alembic Pharmaceuticals Ltd

Cipla Ltd logo

Cipla Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Read More

Alembic Pharmaceuticals Ltd About

Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

2010

Headquarters

CEO

Chirayu R Amin

Employees

Contact

Website icon

Website

http://www.alembicpharmaceuticals.com/

Email icon

Email

apl.investors@alembic.co.in

Phone icon

Phone

91-0265-2280550

Location icon

Location

Alembic Road, , Vadodara, Gujarat, 390003

Read More

Alembic Pharmaceuticals Ltd Company History

YearHistory
2021
  • Alembic receives USFDA tentative approval for Selexipag Tablets.
  • Alembic Pharmaceuticals receives USFDA tentative approval for Dabigatran Etexilate Capsules.
  • Alembic Pharma gets USFDA nod for cancer treatment drug.
  • Alembic Pharmaceuticals has subscribed to partnership interest in ABCD Technologies LLP.
2022
  • Alembic Pharmaceuticals receives USFDA approval for Cyclophosphamide Capsules.
  • Alembic Pharma gets USFDA nod for Entacapone tablets.
  • Alembic Pharmaceuticals gets US FDA nod for antibiotic drug.
2023
  • Alembic has a cumulative total of 182 ANDA approvals from USFDA.
2024
  • Alembic Pharmaceuticals has received USFDA approval for generic Divalproex Sodium delayed-release capsules, used in the treatment of epilepsy.
  • Alembic Pharmaceuticals has received USFDA approval for generic version of Paliperidone extended-release tablets indicated for the treatment of schizophrenia.
  • Alembic Pharmaceuticals has received USFDA approval for the abbreviated new drug application (ANDA) for Ivosidenib tablets of strength 250 mg
2025
  • Alembic Pharmaceuticals Ltd. announces USFDA Final Approval for Travoprost Ophthalmic Solution USP, 0.004% (Ionic Buffered Solution).
  • Alembic Pharmaceuticals Ltd has received final approval from the USFDA for its generic version of Sumatriptan Injection.
  • Alembic Pharmaceuticals has received final approval from the USFDA for its generic version of Carbamazepine extended-release tablets.
  • Alembic Pharmaceuticals Ltd. has received USFDA Final Approval for Ticagrelor Tablets, 60 mg.
  • Alembic Pharmaceuticals Ltd. announces USFDA Final Approval for Bosutinib Tablets, 100 mg and 500 mg.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
ISHARES CORE EMERGING MARKETS MAURITIUS COblockSell184251611.2511 Oct 2022
ISHARES MSCI INDIA SMALL-CAP ETFblockBuy25903611.2511 Oct 2022
ISHARES CORE MSCI EMERGING MARKETS ETFblockBuy184251611.2511 Oct 2022
ISHARES INDIA SC MAURITIUS COMPANYblockSell25903611.2511 Oct 2022
ISHARES INDIA SC MAURITIUS COMPANYblockSell25151604.6503 Oct 2022
ISHARES CORE EMERGING MARKETS MAURITIUS COblockSell178908604.6503 Oct 2022
ISHARES CORE MSCI EMERGING MARKETS ETFblockBuy178908604.6503 Oct 2022
ISHARES MSCI INDIA SMALL-CAP ETFblockBuy25151604.6503 Oct 2022
ISHARES CORE MSCI EMERGING MARKETS ETFblockBuy194642609.919 Sept 2022
ISHARES CORE EMERGING MARKETS MAURITIUS COblockSell194642609.919 Sept 2022

Read More

Alembic Pharmaceuticals Ltd News

Alembic Pharma to host investor meetings on Sep 23

Alembic Pharmaceuticals Ltd will hold one-to-one meetings with institutional investors and analysts in Mumbai on September 23, 2026. The company stated that discussions will be based solely on publicly available information.

18 Sept 2026

companies

Alembic Pharma gets USFDA EIR for Vadodara facility

The US FDA has issued an Establishment Inspection Report, closing its inspection at Alembic Pharmaceuticals' Vadodara bioequivalence facility, signalling regulatory clearance.

16 Sept 2026

companies

Alembic Pharma Gets USFDA Nod for Prucalopride Tablets

Alembic Pharmaceuticals receives final USFDA approval for Prucalopride Tablets, a product with expected US market sales of $100 million.

28 Jul 2026

companies

Alembic Pharma to host Q1 FY27 earnings call

Alembic Pharmaceuticals Limited will hold a post-results conference call on August 4, 2026, at 5:30 PM IST. The session is open to analysts and institutional investors to discuss Q1 FY27 unaudited financial results.

27 Jul 2026

companies

Alembic partner gets USFDA nod for Olaparib

Alembic Pharmaceuticals' partner NATCO Pharma received tentative USFDA approval for Olaparib Tablets. The drug targets a USD 1.4 billion market.

18 Jul 2026

companies

Read More

Frequently Asked Questions

  • 1.What is the stock price of Alembic Pharmaceuticals Ltd?

    As of 28/09/2026 at 12:03 AM, Alembic Pharmaceuticals Ltd shares are trading at ₹844.25.

  • 2.What is the market cap. of Alembic Pharmaceuticals Ltd?

    As of 28/09/2026, the market capitalization of Alembic Pharmaceuticals Ltd is ₹16,714.74 crore.

  • 3.When was Alembic Pharmaceuticals Ltd founded?

    Alembic Pharmaceuticals Ltd was founded in 2010.

  • 4.What are the P/E and P/B ratios of Alembic Pharmaceuticals Ltd?

    As of 28/09/2026, Alembic Pharmaceuticals Ltd has a P/E ratio of 23.93 and a P/B ratio of 3.52.

  • 5.How can I buy shares of Alembic Pharmaceuticals Ltd?

    You can buy shares of Alembic Pharmaceuticals Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.

  • 6.What is the shareholding pattern of Alembic Pharmaceuticals Ltd?

    As of March,2026, promoters hold 69.74% in Alembic Pharmaceuticals Ltd, while FIIs, DIIs and public shareholders hold 4.25%, 16.18% and 9.83%, respectively.

  • 7.Does Alembic Pharmaceuticals Ltd pay dividends?

    Yes, Alembic Pharmaceuticals Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹Final Dividend - Rs. - 11 per share.

  • 8.What is the dividend yield of Alembic Pharmaceuticals Ltd?

    As of 28 September, 2026, the dividend yield of Alembic Pharmaceuticals Ltd stands at 1.42%.

  • 9.What are the latest financial results of Alembic Pharmaceuticals Ltd?

    For January,2024, Alembic Pharmaceuticals Ltd reported revenue of ₹6,551.00 crore and a net profit of ₹583.00 crore.

  • 10.What is the Stock symbol of Alembic Pharmaceuticals Ltd?

    APLLTD is the stock symbol of Alembic Pharmaceuticals Ltd.

  • 11.Who is the CEO of Alembic Pharmaceuticals Ltd?

    The CEO of Alembic Pharmaceuticals Ltd is Chirayu R Amin.